SEC Form 4 · accession 0001967837-26-000010
Bionano Genomics, Inc. · BNGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan V. Dixon
Officer — General Counsel
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 5:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001411690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $1.12 | Aug 3, 2026 | A | 15,000 | A | — | Aug 2, 2036 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date.
- F2The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed.